AI assistant
Sending…
Salarius Pharmaceuticals, Inc. — Director's Dealing 2015
Sep 9, 2015
35494_dirs_2015-09-09_47c83926-af10-44e5-9194-da433241b527.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2015-08-31
Reporting Person: Lindemann Katharine (Chief Operating Officer)
More from Salarius Pharmaceuticals, Inc.
Proxy Solicitation & Information Statement
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 4
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Jan 9
Regulatory Filings
2026
Jan 8